Am. J. Respir. Crit. Care Med., Vol 151, No. 5, 05 1995, 1537-1542.
Genetic susceptibility to atracurium-induced bronchoconstriction
RC Levitt and SL Ewart
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
The goal of this study was to develop a murine model of atracurium- induced
bronchoconstriction in which to evaluate the mechanism of action of this
airway response. We evaluated nine inbred strains of mice for the
development of atracurium-induced bronchoconstriction. The maximal
difference in the magnitude of the airway response to atracurium noted
between the highly responsive DBA/2 mice and the minimally responsive SJL
mice was greater than 20-fold. This phenotype appears to reflect an
intrinsic difference in the lungs of these animals because the extent of
neuromuscular blockade was not significantly different in DBA/2 and SJL
mice. Atracurium-induced airway hyperresponsiveness in DBA/2 mice was
eliminated in a dose- dependent manner by pretreatment with atropine or
pancuronium. These data are consistent with a postganglionic vagal efferent
mechanism which produces a differential pulmonary response to this
neuromuscular blocker. A genetic predisposition to atracurium-induced
bronchoconstriction appears to exist in certain inbred strains of mice.
Thus, a mouse model may be useful for mapping the gene(s) that control this
trait and for suggesting responsible candidate genes. Our results suggest
that the inbred laboratory mouse will be useful to study the mechanism by
which atracurium produces bronchoconstriction.
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Beaty, C. E. Rose Jr., and S.-s. J. Sung
Diverse and Potent Chemokine Production by Lung CD11bhigh Dendritic Cells in Homeostasis and in Allergic Lung Inflammation
J. Immunol.,
February 1, 2007;
178(3):
1882 - 1895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yang, A. Haczku, H. Chen, V. Martin, H. Galczenski, Y. Tomer, C. R. Van Beisen, J. F. Evans, R. A. Panettieri, and C. D. Funk
Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4
Am J Physiol Lung Cell Mol Physiol,
May 1, 2004;
286(5):
L992 - L1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. McLane, A. Haczku, M. van de Rijn, C. Weiss, V. Ferrante, D. MacDonald, J.-C. Renauld, N. C. Nicolaides, K. J. Holroyd, and R. C. Levitt
Interleukin-9 Promotes Allergen-Induced Eosinophilic Inflammation and Airway Hyperresponsiveness in Transgenic Mice
Am. J. Respir. Cell Mol. Biol.,
November 1, 1998;
19(5):
713 - 720.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. C. Nicolaides, K. J. Holroyd, S. L. Ewart, S. M. Eleff, M. B. Kiser, C. R. Dragwa, C. D. Sullivan, L. Grasso, L.-Y. Zhang, C. J. Messler, et al.
Interleukin 9: A candidate gene for asthma
PNAS,
November 25, 1997;
94(24):
13175 - 13180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. DE SANCTIS and J. M. DRAZEN
Genetics of Native Airway Responsiveness in Mice
Am. J. Respir. Crit. Care Med.,
October 1, 1997;
156(4):
S82 - S88.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|